Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer
Waks, Adrienne G., Cohen, Ofir, Kochupurakkal, Bose, Kim, Dewey, Dunn, Connor E., Buendia, Jorge Buendia, Wander, Seth, Helvie, Karla, Lloyd, Maxwell R., Marini, Lori, Hughes, Melissa E., Freeman, SamJournal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.02.008
Date:
February, 2020
File:
PDF, 3.23 MB
2020
File converter
More search results
More benefits 
